Skip to content

Virtual training of the myosignal

Virtual training of the myosignal - Virtual training of the myosignal

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON37573
Enrollment
36
Registered
2012-11-20
Start date
2012-12-03
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

onderarm amputatie arm disability upper limb amputation

Interventions

One group will train myocontrol with their produced myosignal as instantaneous feedback. The second will train using a virtual myoelectric hand and the third group will train using a videogame. All

Sponsors

Rijksuniversiteit Groningen
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: right handed normal or corrected to normal sight

Exclusion criteria

Exclusion criteria: experience with a prosthetic simulator

Design outcomes

Primary

MeasureTime frame
From the discrete test, the range of velocities at which the virtual hand is opened and closed during both pre- and posttest is used to determine the level and improvement of discrete myocontrol. In the continuous test the difference between the myosignals and the target patterns (the patterns that participants had to match their myosignal levels to) are used as outcome measures to determine the level and improvement of the participants* continuous myocontrol ability.

Secondary

MeasureTime frame
Dexterity tests: time to complete the pinboard task (mABC2), force production assessments on the grip force task and scores on the Fitts' task will be used to test prediction of myocontrol learning ability. Hand dominance: the interaction effect between hand dominance and virtual training method will be used to determine whether the dominant and non-dominant hand differ in the training method which has the best effect.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)